Literature DB >> 16680571

Reciprocal interactions between adhesion receptor signaling and MMP regulation.

H G Munshi1, M S Stack.   

Abstract

A predominant characteristic of metastatic cells is the ability to invade host tissues and establish distant metastatic foci. Release of metastatic cells from a primary tumor results from disruption of tissue architecture and requires reversible modulation of cell-matrix and cell-cell contacts, cytoskeletal rearrangement, and acquisition of enhanced proteolytic potential. Malignant cells produce a spectrum of extracellular proteinases including matrix metalloproteinases (MMPs) that process extracellular matrix components, cell surface proteins, and immune modulators. Dysregulated proteolysis has been implicated in tumor invasion and metastasis in multiple model systems. This review will focus on data that highlight the influence of cell-matrix and cell-cell interactions and their associated signal transduction pathways on proteinase regulation. These data highlight cell adhesion signaling as a mechanism for a versatile cellular proteolytic response to changing microenvironmental cues.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680571     DOI: 10.1007/s10555-006-7888-7

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  50 in total

1.  Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT).

Authors:  Laurence Blavier; Alisa Lazaryev; Xiang-He Shi; Frederick J Dorey; Gregory M Shackleford; Yves A DeClerck
Journal:  Cancer Biol Ther       Date:  2010-07-29       Impact factor: 4.742

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Extracellular matrix protein laminin induces matrix metalloproteinase-9 in human breast cancer cell line mcf-7.

Authors:  Sekhar Pal; Shuvojit Moulik; Anindita Dutta; Amitava Chatterjee
Journal:  Cancer Microenviron       Date:  2014-05-26

4.  Spontaneous regression of malignant tumors: Importance of the immune system and other factors (Review).

Authors:  Sante Basso Ricci; Ugo Cerchiari
Journal:  Oncol Lett       Date:  2010-09-23       Impact factor: 2.967

5.  Beta-catenin signaling involves HGF-enhanced HepG2 scattering through activating MMP-7 transcription.

Authors:  Fei-Yan Pan; Sheng-Zhou Zhang; Na Xu; Fan-Li Meng; Hong-Xia Zhang; Bin Xue; Xiao Han; Chao-Jun Li
Journal:  Histochem Cell Biol       Date:  2010-07-31       Impact factor: 4.304

6.  Integrin dynamics produce a delayed stage of long-term potentiation and memory consolidation.

Authors:  Alex H Babayan; Enikö A Kramár; Ruth M Barrett; Matiar Jafari; Jakob Häettig; Lulu Y Chen; Christopher S Rex; Julie C Lauterborn; Marcelo A Wood; Christine M Gall; Gary Lynch
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

7.  The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.

Authors:  Dongsheng Wang; Susan Müller; A R M Ruhul Amin; Donghai Huang; Ling Su; Zhongliang Hu; Mohammad Aminur Rahman; Sreenivas Nannapaneni; Lydia Koenig; Zhengjia Chen; Mourad Tighiouart; Dong M Shin; Zhuo G Chen
Journal:  Clin Cancer Res       Date:  2012-07-24       Impact factor: 12.531

8.  Integrin signaling aberrations in prostate cancer.

Authors:  Hira Lal Goel; Naved Alam; Isaac N S Johnson; Lucia R Languino
Journal:  Am J Transl Res       Date:  2009-04-20       Impact factor: 4.060

9.  Immunoexpression of metalloproteinases 2 and 14 and TIMP-2 inhibitor in main types of primary gastric carcinomas and lymph node metastasis.

Authors:  Daniel Cordeiro Gurgel; José Telmo Valença-Junior; Conceição Aparecida Dornelas; Renato Braga Vieira; João Tarcisio Alves Maia-Filho; Roberto Cesar Pereira Lima-Junior; Ronaldo Albuquerque Ribeiro; Paulo Roberto Carvalho Almeida
Journal:  Pathol Oncol Res       Date:  2014-05-07       Impact factor: 3.201

Review 10.  Defining the role of integrin alphavbeta6 in cancer.

Authors:  A Bandyopadhyay; S Raghavan
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.